首页> 外文OA文献 >A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

【2h】

A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

机译：用于先进预处理的恶性胸膜间皮瘤（MPM）的Pembrolizumab（P）与单一药物化疗（CT）的多期式随机阶段III试验（CT）：欧洲胸肿瘤学平台（ETOP 9-15）承诺 - 中文试验结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
S. Popat; A. Curioni-Fontecedro; V. Polydoropoulou; R. Shah; M. O’Brien; A. Pope; P. Fisher; J. Spicer; A. Roy; D. Gilligan; O. Gautschi; E. Nadal; W.-D. Janthur; R. López Castro; R. García Campelo; H. Roschitzki-Voser; B. Ruepp; S. Rusakiewicz; S. Peters; R.A. Stahel;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small-cell lung cancer: results of a west Japan thoracic oncology group trial (WJTOG0203). [J] . Takeda K, Hida T, Sato Journal of Clinical Oncology . 2010,第5期

机译：在日本晚期晚期非小细胞肺癌患者中进行的铂双药化疗随后进行吉非替尼与持续铂双药化疗的III期随机试验：一项西日本胸腔肿瘤小组试验的结果（WJTOG0203）。
2. Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14) [J] . Peters Solange, Felip Enriqueta, Dafni Urania, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2021,第2期

机译：在当地先进的阶段IIIA-B NSCLC中具有标准同时化疗的无进展和整体生存，并在局部高级阶段进行标准同时进行化学疗法：欧洲胸部肿瘤学平台尼古拉斯第二阶段试验（欧洲胸脑肿瘤平台6-14）
3. Randomized phase III trial comparing single-agent paclitaxel Poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer. [J] . OBrien ME, Socinski MA, Popovich AY, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2008,第7期

机译：比较单药紫杉醇Poliglumex（CT-2103，PPX）与单药吉西他滨或长春瑞滨治疗PS 2初治性晚期非小细胞肺癌患者的随机III期试验。
4. Feasibility trial assessing intrapleural photodynamic therapy combined with pleurectomy/decortication then chemotherapy in malignant pleural mesothelioma patients. [C] . Serge Mordon, Camille Munck, Ecaterina Surmei-Pintilie, International Photodynamic Association World Congress . 2019

机译：可行性试验评估腹膜内光动力学治疗与胸膜切除术/凝固患者患者在恶性胸膜间皮瘤患者中相结合。
5. MesoTRAP: a feasibility study that includes a pilot clinical trial comparing video-assisted thoracoscopic partial pleurectomy decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial [O] . Claire Matthews, Carol Freeman, Linda D Sharples, 2019

机译：MesoTRAP：一项可行性研究包括一项试验性临床试验该试验比较了由于恶性胸膜间皮瘤而在被困肺部患者中采用视频辅助胸腔镜部分胸膜切除术与留置胸膜导管进行胸膜肺切除术旨在解决III期临床试验的募集和随机性不确定性以及样本量要求
6. Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial [O] . Solange Peters, Rolf A. Stahel, Urania Dafni, 2017

机译：随机的Erlotinib对多西紫杉醇的Arlotinib与多西紫杉醇的试验失败的一线铂类双细胞化疗，由Veristrat良好的veristrat差分层。欧洲胸肿瘤学平台（ETOP）重点肺试验

A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

著录项

相似文献

相关主题

期刊订阅